PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Clinical studies of C. lechleri products reported positive results in treating traveler's and watery diarrhea and symptoms of insect bites [PMID:14736360]
Clinical studies reflect wound healing properties [PMID:30556246]; in vivo rat models showed stimulated wound contraction and epithelial regeneration [PMID:23196095]
Dragon blood resin ameliorates SIONFH through osteoclastic pathways in rat models [PMID:37675145]
The oligomer SP-303 from C. lechleri shows potent activity against RSV, FLU-A, PIV, HSV-1, HSV-2, and hepatitis A and B in cell culture [PMID:23195881]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 14736360 (2003) — Review of sangre de drago (Croton lechleri)--a South American tree sap in the treatment of diarrhea, inflammation, insect bites, viral infections, and wounds: traditional uses to clinical research. · Journal of alternative and complementary medicine (New York, N.Y.)
- 2.PMID: 30556246 (2019) — Review of future insights of Dragon's Blood in dermatology. · Dermatologic therapy
- 3.PMID: 37675145 (2023) — Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways. · Frontiers in cell and developmental biology
- 4.PMID: 14598201 (2003) — Immunomodulatory activity and chemical characterisation of sangre de drago (dragon's blood) from Croton lechleri. · Planta medica
- 5.PMID: 20698880